Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
9402875
Publication Date
8-2-2016
Abstract
The present invention relates to the use of novel proteins, referred to herein as amidated glial cell line-derived neurotrophic factor (GDNF) peptides (or “Amidated Dopamine Neuron Stimulating peptides (ADNS peptides)”), for treating brain diseases and injuries that result in dopaminergic deficiencies and mitochodrial dysfunction, e.g., reduced complex I enzyme activity.
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
13/586,617
Filing Date
08/15/2012
Recommended Citation
Bradley, Luke H.; Gash, Don M.; and Gerhardt, Greg A., "Amidated Dopamine Neuron Stimulating Peptide Restoration of Mitochondrial Activity" (2016). Neuroscience Faculty Patents. 9.
https://uknowledge.uky.edu/neurobio_patents/9
